AMOLYT PHARMA Trademark

Trademark Overview

On Monday, April 27, 2020, a trademark application was filed for AMOLYT PHARMA with the United States Patent and Trademark Office. The USPTO has given the AMOLYT PHARMA trademark a serial number of 79286937. The federal status of this trademark filing is REGISTERED as of Tuesday, April 20, 2021. This trademark is owned by AMOLYT PHARMA. The AMOLYT PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services for pharmaceutical preparations
amolyt pharma

General Information

Serial Number79286937
Word MarkAMOLYT PHARMA
Filing DateMonday, April 27, 2020
Status700 - REGISTERED
Status DateTuesday, April 20, 2021
Registration Number6324872
Registration DateTuesday, April 20, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2021

Trademark Statements

Pseudo MarkAMOLYT PHARMACY
NOT AVAILABLE"PHARMA"
Goods and ServicesResearch and development services for pharmaceutical preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 5, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAMOLYT PHARMA
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameAMOLYT PHARMA
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameAMOLYT PHARMA
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Thursday, June 4, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, June 9, 2020APPLICATION FILING RECEIPT MAILED
Thursday, July 16, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 20, 2020ASSIGNED TO EXAMINER
Wednesday, July 22, 2020NON-FINAL ACTION WRITTEN
Thursday, August 27, 2020REFUSAL PROCESSED BY MPU
Wednesday, October 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 28, 2020ASSIGNED TO LIE
Monday, December 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 23, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 5, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, September 27, 2020REFUSAL PROCESSED BY IB
Wednesday, January 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 30, 2021NOTIFICATION PROCESSED BY IB
Tuesday, April 20, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, January 13, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 13, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 29, 2021FINAL DISPOSITION PROCESSED
Thursday, July 29, 2021FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, August 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 12, 2025NEW REPRESENTATIVE AT IB RECEIVED
Saturday, August 14, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, November 11, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, July 7, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

pharma amolyt preparations pharmaceutical services development research